Jill Wu
Stock Analyst at CMB International Securities
(4.82)
# 472
Out of 5,010 analysts
202
Total ratings
56.2%
Success rate
26.5%
Average return
Main Sectors:
Stocks Rated by Jill Wu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2637 Fujian Haixi Pharmaceuticals Co., Ltd. | Reiterated: Buy | $280.00 | $171.20 | +63.55% | 2 | Sep 18, 2026 | |
| HKG: 6699 Angelalign Technology Inc. | Reiterated: Buy | $91.89 → $114.21 | $86.30 | +32.34% | 5 | Sep 2, 2026 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Reiterated: Buy | $383.47 → $284.50 | $202.20 | +40.70% | 4 | Sep 1, 2026 | |
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $185.80 → $138.42 | $109.00 | +26.99% | 11 | Aug 31, 2026 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Reiterated: Buy | $47.19 → $49.12 | $35.38 | +38.84% | 9 | Aug 28, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $113.86 → $130.25 | $97.90 | +33.04% | 14 | Aug 27, 2026 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $39.00 → $60.00 | $55.60 | +7.91% | 11 | Aug 27, 2026 | |
| HKG: 2268 WuXi XDC Cayman Inc. | Reiterated: Buy | $82.00 → $93.00 | $81.40 | +14.25% | 4 | Aug 25, 2026 | |
| HKG: 1530 3SBio Inc. | Reiterated: Buy | $34.87 → $34.78 | $16.26 | +113.90% | 11 | Aug 24, 2026 | |
| HKG: 2696 Shanghai Henlius Biotech, Inc. | Reiterated: Buy | $99.78 → $101.66 | $58.00 | +75.28% | 8 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13.05 → $13.44 | $10.06 | +33.60% | 16 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92.55 → $99.58 | $64.70 | +53.91% | 5 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38.70 → $38.42 | $24.30 | +58.11% | 11 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $507.11 → $642.29 | $489.40 | +31.24% | 10 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $392 → $442 | $365.27 | +21.09% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $36 | $28.72 | +24.48% | 2 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $620 → $660 | $679.61 | -2.89% | 8 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11.95 → $18.31 | $14.75 | +24.14% | 4 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9.40 → $8.70 | $5.71 | +52.36% | 4 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10.34 | $6.12 | +68.95% | 1 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80.27 | $51.60 | n/a | 1 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34.03 → $31.39 | $23.42 | n/a | 6 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.57 | $8.13 | n/a | 2 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35.04 → $33.68 | $34.12 | n/a | 3 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21.41 → $52.39 | $5.13 | n/a | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19.59 → $21.09 | $76.80 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.43 → $3.33 | $2.18 | n/a | 3 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10.36 → $8.57 | $30.66 | n/a | 6 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.20 → $5.27 | $4.85 | n/a | 4 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.65 | $0.80 | n/a | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16.01 → $13.78 | $0.49 | n/a | 2 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22.36 | $69.50 | n/a | 1 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23.89 → $23.80 | $6.36 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $57.97 | $3.44 | n/a | 1 | Aug 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.15 | $11.80 | n/a | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.37 | n/a | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $33.21 | $1.02 | n/a | 1 | Jul 24, 2023 |
Fujian Haixi Pharmaceuticals Co., Ltd.
Sep 18, 2026
Reiterated: Buy
Price Target: $280.00
Current: $171.20
Upside: +63.55%
Angelalign Technology Inc.
Sep 2, 2026
Reiterated: Buy
Price Target: $91.89 → $114.21
Current: $86.30
Upside: +32.34%
Duality Biotherapeutics, Inc.
Sep 1, 2026
Reiterated: Buy
Price Target: $383.47 → $284.50
Current: $202.20
Upside: +40.70%
Akeso, Inc.
Aug 31, 2026
Reiterated: Buy
Price Target: $185.80 → $138.42
Current: $109.00
Upside: +26.99%
Hansoh Pharmaceutical Group Company Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $47.19 → $49.12
Current: $35.38
Upside: +38.84%
Innovent Biologics, Inc.
Aug 27, 2026
Reiterated: Buy
Price Target: $113.86 → $130.25
Current: $97.90
Upside: +33.04%
WuXi Biologics (Cayman) Inc.
Aug 27, 2026
Reiterated: Buy
Price Target: $39.00 → $60.00
Current: $55.60
Upside: +7.91%
WuXi XDC Cayman Inc.
Aug 25, 2026
Reiterated: Buy
Price Target: $82.00 → $93.00
Current: $81.40
Upside: +14.25%
3SBio Inc.
Aug 24, 2026
Reiterated: Buy
Price Target: $34.87 → $34.78
Current: $16.26
Upside: +113.90%
Shanghai Henlius Biotech, Inc.
Aug 24, 2026
Reiterated: Buy
Price Target: $99.78 → $101.66
Current: $58.00
Upside: +75.28%
Aug 21, 2026
Reiterated: Buy
Price Target: $13.05 → $13.44
Current: $10.06
Upside: +33.60%
Aug 20, 2026
Reiterated: Buy
Price Target: $92.55 → $99.58
Current: $64.70
Upside: +53.91%
Aug 19, 2026
Reiterated: Buy
Price Target: $38.70 → $38.42
Current: $24.30
Upside: +58.11%
Aug 19, 2026
Reiterated: Buy
Price Target: $507.11 → $642.29
Current: $489.40
Upside: +31.24%
Aug 7, 2026
Reiterated: Buy
Price Target: $392 → $442
Current: $365.27
Upside: +21.09%
Aug 7, 2026
Reiterated: Buy
Price Target: $35 → $36
Current: $28.72
Upside: +24.48%
Jul 27, 2026
Reiterated: Buy
Price Target: $620 → $660
Current: $679.61
Upside: -2.89%
Apr 24, 2026
Reiterated: Buy
Price Target: $11.95 → $18.31
Current: $14.75
Upside: +24.14%
Mar 30, 2026
Reiterated: Buy
Price Target: $9.40 → $8.70
Current: $5.71
Upside: +52.36%
Mar 12, 2026
Reiterated: Buy
Price Target: $10.34
Current: $6.12
Upside: +68.95%
Sep 3, 2025
Initiated Coverage: Buy
Price Target: $80.27
Current: $51.60
Upside: n/a
Aug 11, 2025
Reiterated: Buy
Price Target: $34.03 → $31.39
Current: $23.42
Upside: n/a
Apr 3, 2025
Reiterated: Buy
Price Target: $7.57
Current: $8.13
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $35.04 → $33.68
Current: $34.12
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $21.41 → $52.39
Current: $5.13
Upside: n/a
Oct 31, 2024
Reiterated: Buy
Price Target: $19.59 → $21.09
Current: $76.80
Upside: n/a
Sep 2, 2024
Reiterated: Buy
Price Target: $4.43 → $3.33
Current: $2.18
Upside: n/a
Sep 2, 2024
Reiterated: Buy
Price Target: $10.36 → $8.57
Current: $30.66
Upside: n/a
Aug 30, 2024
Reiterated: Buy
Price Target: $7.20 → $5.27
Current: $4.85
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: $1.65
Current: $0.80
Upside: n/a
Apr 9, 2024
Reiterated: Buy
Price Target: $16.01 → $13.78
Current: $0.49
Upside: n/a
Aug 29, 2023
Reiterated: Buy
Price Target: $22.36
Current: $69.50
Upside: n/a
Aug 28, 2023
Reiterated: Buy
Price Target: $23.89 → $23.80
Current: $6.36
Upside: n/a
Aug 25, 2023
Initiated Coverage: Buy
Price Target: $57.97
Current: $3.44
Upside: n/a
Aug 23, 2023
Reiterated: Buy
Price Target: $8.15
Current: $11.80
Upside: n/a
Aug 3, 2023
Rated: Hold
Price Target: n/a
Current: $1.37
Upside: n/a
Jul 24, 2023
Initiated Coverage: Buy
Price Target: $33.21
Current: $1.02
Upside: n/a